|
|
Nearly 31 million adults in America have a total cholesterol level that is more than 240 mg per dL.
Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.
Hyperthyroidism leads to an increased rate of metabolism and affects about 1% of women but only 0.1% of men. For most people, this increased metabolic rate causes the thyroid gland to become enlarged (known as a goiter).
Women are 50% to 75% more likely than men to experience an adverse drug reaction.
More than nineteen million Americans carry the factor V gene that causes blood clots, pulmonary embolism, and heart disease.